Anti-Mllerian Hormone (AMH) is a glycoprotein hormone produced by granulosa cells in ovarian follicles. AMH levels serve as an indicator of ovarian reserve, reflecting the quantity of remaining eggs in a woman’s ovaries. Lowered levels may signify diminished ovarian reserve, potentially impacting fertility. While directly elevating specific hormone measurements might not always be achievable, lifestyle and medical interventions can positively influence reproductive health and follicular function, contributing to a more favorable hormonal environment. For example, managing stress and maintaining a healthy weight have been shown to indirectly support hormonal balance.
Maintaining adequate AMH levels is important as it can provide insights into a woman’s reproductive lifespan and responsiveness to fertility treatments. Historically, assessing ovarian reserve relied heavily on age and menstrual cycle day 3 follicle-stimulating hormone (FSH) levels. AMH offered a more direct and age-independent marker, improving the accuracy of fertility assessments. Understanding and addressing factors that may contribute to declining ovarian reserve can empower individuals to make informed decisions about family planning and explore proactive reproductive strategies.